Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD
PHASE1
The purpose of this study is to assess the pharmakokinetic properties of hi...
Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial
PHASE4
Iron deficiency anemia is a common complication in patients who underwent g...
Status
Unknown
Location
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia
PHASE1
The purpose of this study is to assess Pharmakokinetic properties of iron i...
A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D
PHASE3
The purpose of this study is to compare the efficacy and safety of intraven...